Impax Laboratories Inc (NASDAQ:IPXL)

46.21
Delayed Data
As of May 22
 +0.75 / +1.65%
Today’s Change
22.12
Today|||52-Week Range
52.10
+45.86%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues188.1M158.0M131.2M143.1M
 
 
 
 
 
Cost of Goods Sold70.1M65.3M60.9M73.4M
 
 
 
 
 
Depreciation And Amortization8.3M8.2M9.5M10.4M
 
 
 
 
 
 
Operating ExpensesGross Income109.8M84.4M60.8M59.2M
 
 
 
 
 
General Expenses54.1M57.9M59.3M62.8M
 
 
 
 
 
Research And Development21.3M19.0M17.1M15.0M
 
 
 
 
 
Total Operating Expenses132.4M131.4M129.7M146.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income55.7M26.6M1.5M-3.6M
 
 
 
 
 
Extraordinary Charge-1.8M-1.1M-4.3M-3.3M
 
 
 
 
 
Interest Expense On Debt----0.004.0M
 
 
Other Expenses124.0K-17.0K4.1M-166.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income54.4M25.9M1.7M-10.7M
 
 
 
 
 
Income Taxes-19.4M-10.1M-1.5M-4.4M
 
 
 
 
 
Net Income35.1M15.7M120.0K-6.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS68.1M68.3M68.7M69.0M
 
 
 
 
 
Shares To Calculate EPS Diluted70.3M70.7M71.0M69.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.50$0.22$0.00-$0.09
 
 
 
 
EPS Diluted$0.50$0.22$0.00-$0.09
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account